NeuroBo Pharmaceuticals (NRBO) Competitors $0.66 +0.01 (+1.82%) As of 07/2/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock NRBO vs. WVFC, BTCT, KFFB, GREE, SOS, JFU, ANY, GLBZ, SAIH, and MCVTShould you be buying NeuroBo Pharmaceuticals stock or one of its competitors? The main competitors of NeuroBo Pharmaceuticals include WVS Financial (WVFC), BTC Digital (BTCT), Kentucky First Federal Bancorp (KFFB), Greenidge Generation (GREE), SOS (SOS), 9F (JFU), Sphere 3D (ANY), Glen Burnie Bancorp (GLBZ), SAIHEAT (SAIH), and Mill City Ventures III (MCVT). These companies are all part of the "banking" industry. NeuroBo Pharmaceuticals vs. Its Competitors WVS Financial BTC Digital Kentucky First Federal Bancorp Greenidge Generation SOS 9F Sphere 3D Glen Burnie Bancorp SAIHEAT Mill City Ventures III WVS Financial (NASDAQ:WVFC) and NeuroBo Pharmaceuticals (NASDAQ:NRBO) are both small-cap banking companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, institutional ownership, risk, dividends, earnings, profitability, media sentiment and analyst recommendations. Does the media refer more to WVFC or NRBO? In the previous week, NeuroBo Pharmaceuticals had 1 more articles in the media than WVS Financial. MarketBeat recorded 1 mentions for NeuroBo Pharmaceuticals and 0 mentions for WVS Financial. WVS Financial's average media sentiment score of 0.00 equaled NeuroBo Pharmaceuticals'average media sentiment score. Company Overall Sentiment WVS Financial Neutral NeuroBo Pharmaceuticals Neutral Do institutionals and insiders have more ownership in WVFC or NRBO? 6.3% of WVS Financial shares are held by institutional investors. Comparatively, 1.4% of NeuroBo Pharmaceuticals shares are held by institutional investors. 13.5% of WVS Financial shares are held by insiders. Comparatively, 1.1% of NeuroBo Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Which has more volatility & risk, WVFC or NRBO? WVS Financial has a beta of 0.11, meaning that its share price is 89% less volatile than the S&P 500. Comparatively, NeuroBo Pharmaceuticals has a beta of -0.26, meaning that its share price is 126% less volatile than the S&P 500. Is WVFC or NRBO more profitable? WVS Financial has a net margin of 9.50% compared to NeuroBo Pharmaceuticals' net margin of 0.00%. WVS Financial's return on equity of 12.31% beat NeuroBo Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets WVS Financial9.50% 12.31% 1.29% NeuroBo Pharmaceuticals N/A -189.12%-122.31% Which has better valuation and earnings, WVFC or NRBO? WVS Financial has higher revenue and earnings than NeuroBo Pharmaceuticals. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioWVS Financial$5.13M4.61$1.38M$1.0212.25NeuroBo PharmaceuticalsN/AN/A-$12.47MN/AN/A SummaryWVS Financial beats NeuroBo Pharmaceuticals on 8 of the 9 factors compared between the two stocks. Get NeuroBo Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for NRBO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NRBO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NRBO vs. The Competition Export to ExcelMetricNeuroBo PharmaceuticalsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$5.70M$783.59M$5.49B$9.01BDividend YieldN/A4.84%5.39%4.09%P/E RatioN/A1.3127.4320.06Price / SalesN/A217.25398.25108.31Price / CashN/A23.4436.1356.90Price / Book0.446.108.085.67Net Income-$12.47M-$27.81M$3.16B$248.47M7 Day Performance-2.58%0.67%2.12%2.90%1 Month Performance1.12%7.16%4.43%5.75%1 Year Performance-85.20%7.88%35.62%21.36% NeuroBo Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NRBONeuroBo PharmaceuticalsN/A$0.66+1.8%N/A-86.1%$5.70MN/A0.0010News CoverageGap UpWVFCWVS FinancialN/A$12.20+0.6%N/AN/A$23.10M$5.13M12.4420BTCTBTC Digital1.1988 of 5 stars$3.02+6.2%N/A+61.9%$22.65M$11.68M0.0016Gap UpKFFBKentucky First Federal Bancorp0.088 of 5 stars$2.70+0.4%N/A-5.5%$21.84M$16.53M-20.7760GREEGreenidge Generation4.439 of 5 stars$1.25+7.5%$4.00+220.8%-51.5%$19.38M$59.53M0.00680News CoverageSOSSOSN/A$5.84+5.2%N/A-51.1%$18.10M$231.42M0.00170JFU9FN/A$1.47-0.7%N/A-30.8%$17.30M$58.09M0.00740Positive NewsGap UpANYSphere 3D1.6119 of 5 stars$0.55+5.2%$3.00+448.4%-41.6%$14.47M$16.61M-0.9620Gap UpGLBZGlen Burnie Bancorp0.7856 of 5 stars$4.74+1.2%N/A+32.3%$13.73M$16.37M473.9780Gap UpSAIHSAIHEATN/A$7.36+1.7%N/AN/A$12.89M$5.54M0.0037MCVTMill City Ventures III2.3695 of 5 stars$1.88+1.4%N/A-37.3%$11.36M$3.30M9.872 Related Companies and Tools Related Companies WVS Financial Alternatives BTC Digital Alternatives Kentucky First Federal Bancorp Alternatives Greenidge Generation Alternatives SOS Alternatives 9F Alternatives Sphere 3D Alternatives Glen Burnie Bancorp Alternatives SAIHEAT Alternatives Mill City Ventures III Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NRBO) was last updated on 7/3/2025 by MarketBeat.com Staff From Our PartnersTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NeuroBo Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NeuroBo Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
